Filters

See more specimen types...

Other countries

See more countries

Results: 1 to 20 of 63

Tests names and labsConditionsGenes and analytesMethods

LRRK2

Institute for Human Genetics University Clinic Freiburg
Germany
11
  • C Sequence analysis of the entire coding region

Detection of the G2019S mutation in exon 41 of the LRRK2 gene

Neurogenetics Department Cyprus Institute of Neurology and Genetics
Cyprus
11
  • T Targeted variant analysis

LRRK2(PARK8) - Gene Sequencing & Del/Dup analysis

Amsterdam UMC Genome Diagnostics VU University medical center
Netherlands
21
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • T Targeted variant analysis

Parkinson Disease via the LRRK2 Gene

PreventionGenetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Parkinson disease 8, 607060, Autosomal dominant; PARK8 (Hereditary late-onset Parkinson disease) (LRRK2 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • C Sequence analysis of the entire coding region

LRRK2. Complete sequencing

Instituto de Medicina Genomica
Spain
11
  • C Sequence analysis of the entire coding region

LRRK2. Sequencing of the exons 31, 35 and 41

Instituto de Medicina Genomica
Spain
11
  • E Sequence analysis of select exons

LRRK2 Single Gene

Fulgent Genetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Parkinson disease 8 (PARK8, deletion/duplication analysis on LRRK2 gene)

CGC Genetics
Portugal
11
  • D Deletion/duplication analysis

Parkinson disease type 8 (PARK8, sequence analysis of exon 41 of LRRK2 gene)

CGC Genetics
Portugal
11
  • C Sequence analysis of the entire coding region

Parkinson disease (deletion/duplication analysis on PARK2, PARK7, ATP13A2, PINK1, SNCA, LRRK2, UCHL1 and GCH1 genes)

CGC Genetics
Portugal
98
  • D Deletion/duplication analysis

Parkinson Disease , Deletions-Duplications (MLPA) SNCA, PARK2, PINK1, PARK7, LRRK2, UCHL1 Genes

Reference Laboratory Genetics
Spain
66
  • D Deletion/duplication analysis

Parkinson Disease Type 8, Screening Frequent Mutations LRRK2 (PARK8) Gene

Reference Laboratory Genetics
Spain
11
  • E Sequence analysis of select exons

Parkinson Disease Type 8, Sequencing LRRK2 (PARK8) Gene

Reference Laboratory Genetics
Spain
11
  • C Sequence analysis of the entire coding region

LRRK2 DNA Test

Athena Diagnostics Inc
United States
11
  • E Sequence analysis of select exons

Single gene testing LRRK2

CeGaT GmbH
Germany
11
  • C Sequence analysis of the entire coding region

Parkinson Disease (LRRK2 gene)

Diagnostic Service Facility University of Antwerp
Belgium
11
  • E Sequence analysis of select exons

LRRK2 DNA Sequencing Test

Athena Diagnostics Inc
United States
11
  • C Sequence analysis of the entire coding region

Parkinson disease (Park-8): LRRK2 gene sequence analysis

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
11
  • C Sequence analysis of the entire coding region

Parkinson disease 8: LRRK2 (PARK8) gene screening

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
11
  • E Sequence analysis of select exons

Results: 1 to 20 of 63

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center